BRAF and cancer: We were also interested in evaluating NFE2L2 mRNA expression in relation to BRAF and KRAS mutations, since mutations to these genes occur frequently in PTC [7], and mutated KRAS and BRAF are associated with increased transcription of NFE2L2 in other cancers [8].